Venture Capital Investors

Tang Capital Management

Tang Capital Management is focused on making venture capital investments in high-tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Tang Capital Management, LLC (Tang Capital) is a life sciences-focused investment firm with a strong track record of creating and building successful biopharmaceutical companies. The principal of Tang Capital founded Ardea Biosciences, Inc. in 2006 and served as its director until its acquisition by AstraZeneca PLC in June 2012. The principal of Tang Capital currently serves as Chairman of Heron Therapeutics, Inc. (NASDAQ: HRTX), La Jolla Pharmaceutical Company (NASDAQ: LJPC), and as the Chairman and Chief Executive Officer of Odonate Therapeutics, Inc. (NASDAQ: ODT).

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/24/2019

Transaction History

Our records indicate that Tang Capital Management invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Managing Director

Kevin Tang

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Tang Capital Management has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Tané Labs | Tanglin Venture Partners

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary